IP6K1 and cancer: To determine if the reduced invasion potential of IP6K1 depleted cancer cells extends to Ip6k1 knockout cells in vivo we utilized the 4-nitroquinoline 1-oxide (4NQO) oral squamous cell carcinoma model [43].